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TECHNICAL NOTE
Rapid measurement of glomerular filtration rate in
small animals
YASUO IDO, RONALD G. TILTON, KATHERINE CHANG, GIUSEPPE PUGLIESE,'
and JOSEPH R. WILLIAMSON
Washington University School of Medicine, Department of Pathology, St. Louis, Missouri, USA
The conventional inulin clearance method for estimating
GFR in experimental animals requires extensive surgery as well
as continuous intravenous infusion of fluids and maintenance of
body temperature, arterial hematocrit, and blood pressure
during the collection of multiple urine samples over a prolonged
time period. To obviate these problems, a number of single
bolus tracer-injection techniques have been developed for esti-
mating GFR [1—5]. These methods are based on several assump-
tions, including rapid distribution of tracer [1], a two-compart-
ment tracer distribution [2, 31, and identical tracer distribution
volumes in different animals [4]; any one or more of these
assumptions may not be valid in pathophysiological conditions
such as expanded extracellular fluid volume [5], diabetes [61,
etc. The frequent blood sampling necessary to obtain reliable
curve fitting [1—3, 5] is a particular problem for measuring GFR
by these methods in small animals. Conventional inulin clear-
ance (which requires relatively long urine collection times) and
single-injection techniques (which require frequent blood sam-
pling) may be especially difficult to perform on small animals in
poor health, such as, diabetes.
The single bolus tracer-injection method for assessing GFR
described in this report is: 1) independent of urine flow rate, 2)
noninvasive (to the urinary tract), 3) requires no assumptions
regarding the number of compartments in which the tracer is
distributed or the general form of the plasma tracer activity
curve, and 4) can be completed in less than 10 minutes following
cannulation of vessels for injection of radiolabeled tracers and
withdrawal of blood samples. Estimates of GFR obtained by
this method agree closely with those obtained by conventional
inulin clearance. The major limitation of the method is that it
can be used only terminally, since the kidneys, ureters, and
bladder are removed for quantification of tracer activity.
Methods
All rats were housed and cared for in accordance with the
guidelines of the University Committee for the Humane Care of
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Laboratory Animals and in accordance with NIH guidelines on
laboratory animal welfare. Male Sprague-Dawley rats weighing
250 to 300 g were housed individually, allowed food and water
ad libitum, and were on a 12-hour light/dark cycle. Rats were
randomly allocated to the following groups: Group 1, rats with
untreated diabetes of two weeks duration (plasma glucose =
352 to 425 mg/dl); Group 2, rats with diabetes of four weeks
duration given 2 to 4 U of heat-treated ultralente bovine insulin
(Novo) per day (plasma glucose = 290 to 510 mg/dl) beginning
one week after induction of diabetes; Group 3, rats with
untreated diabetes of four weeks duration (plasma glucose =
512 to 730 mg/dl), and Group 4, age-matched nondiabetic
control rats. Diabetes was induced by intraperitoneal injection
of streptozotocin (Zanozar; Upjohn, 55 mg/kg body weight).
Radiocobaltic EDTA (57Co-EDTA, mol wt 349) was prepared
by a modification [7] of the method of Bridge et a! [8] for
preparation of 58Co-EDTA. 57Co-EDTA was chosen in prefer-
ence to '4C-inulin and other tracers because: 1) the affinity of
Co3 for EDTA is extremely high [8], 2) it is an extracellular
space marker that does not bind to tissue components [8, 9],
and 3) 57Co has a relatively low gamma emission (122 to 136
keV) and long half-life (270 days). Therefore it can be quantified
by gamma spectrometry (which is much more convenient than
quantification of beta-emitting isotopes by liquid scintillation
spectrometry). Methoxy-14C-inulin (14.4 mCi/g, mol wt —5,000)
was purchased from NEN (Boston, Massachusetts, USA) for
conventional inulin clearance.
In a preliminary experiment, 57Co-EDTA was injected into
the left femoral vein of two controls and two rats with untreated
diabetes of two weeks duration; 100 .d of blood was sampled
from an arterial cannula after 0.25, 0.5, 1, 2, 5, 10, and 20
minutes. In the first experiment, GFR was measured in six
control and eight Group I diabetic rats by conventional '4C-
inulin clearance, followed immediately by assessment of GFR
based on 57Co-EDTA clearance as detailed below. In a second
experiment, effects of diabetes (with and without insulin ther-
apy) on GFR were assessed with the 57Co-EDTA clearance
technique only.
For the first experiment, rats were anesthetized by intraperi-
toneal injection of mactin (100 mg/kg body weight); body
(rectal) temperature was maintained at 37 0.5°C using heat
lamps and a 37°C surgical tray. The trachea was intubated, the
right and left femoral arteries were cannulated with 0.5 mm i.d.
clear vinyl tubing (Dural Plastics and Engineering, Auburn,
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Australia), rinsed with heparin (200 U/mi) for sampling arterial
blood and monitoring blood pressure, and the left femoral vein
was cannulated for injection of radiolabeled tracers. The left
ureter was cannulated with PE-lO tubing through a small
midline abdominal incision for collection of urine. To compen-
sate for loss of body fluids during surgery, 5% bovine serum
albumin in 0.9% saline (1% of body weight) was infused over
the next 30 minutes [101, then at the rate of 0.55 mi/hr for
controls and 1.1 mi/hr for diabetics during a 60-minute equili-
bration period and during each of two subsequent 30-minute
urine collections [11]. Following the first 30 minutes of fluid
supplementation, —10 Ci '4C-inulin (NEN) in 3 ml of 0.9%
saline was infused at the rate of 1.1 mi/hr. Fifty microliter blood
samples were obtained at the midpoint of each urine collection.
14C-inuiin in plasma and urine was quantified by beta-scintiila-
tion spectrometry.
Five minutes after the last urine collection for '4C-inulin
clearance, the left femoral artery cannula was connected to a 1
ml syringe (previously rinsed with heparin) attached to a
Harvard Model 940 constant withdrawal pump preset to with-
draw at a constant rate of 0.055 milmin. 57Co-EDTA (—0.1 Ci
in 0.2 ml of saline) was injected via the femoral vein, and the
withdrawal pump was started simultaneously. Five minutes
later, the withdrawal pump was stopped, the rat was killed by
quickly opening the chest cavity and severing the aorta at the
base of the heart, and the left kidney with its ureter and PE
tubing was removed intact. 57Co-EDTA in the kidney, tubing,
and urine and in the blood from the withdrawal pump was
quantified by gamma-spectrometry. Both spectrometers were
interfaced to a Hewlett-Packard I000A-series computer in
which the data were corrected for background and stored for
anaiysis.
For the second experiment in which only 57Co-EDTA clear-
ance was assessed, rats were anesthetized, the trachea was
intubated, vessels were cannuiated, the withdrawal pump was
connected as described above, and saline (0.5% body weight)
was injected intraperitoneally for fluid supplementation. 57Co-
EDTA (—0.1 pCi in 0.2 ml saline) was injected via the femoral
vein and five minutes later both kidneys, ureters, and the
bladder (with urine) were removed intact. Tracer activity in the
tissues and in the withdrawal pump blood was quantified as
described above. Immediately prior to stopping the pump —100
p1 of arterial biood was taken for determination of arterial
hematocrit. The hematocrit was derived from the average of 2
microhematocrit tubes after a five minute spin in a IEC centri-
fuge (model MB) at 12,000g. In some rats 1251-BSA (—0.1 pCi)
was injected together with 57Co-EDTA to assess 57Co-EDTA in
the vasculature of the kidneys (as well as in the ureters and
bladder). Alter a five minute circulation time very little of the
'251-BSA in tissues had permeated vessel walls into extravas-
cular spaces; thus, the tissue content of '251-BSA provided an
intravascular space (reference) tracer [12]. Kidney, ureter, and
biadder plasma volume equivalents of '251-BSA and 57Co-
EDTA were determined from the piasma content of both tracers
in an arterial blood sample obtained just as the withdrawal
pump was stopped. 1251-BSA was prepared by the iodogen
procedure [13], separated from free 125j by column centrifuga-
tion, and dialyzed against Krebs-Henseleit buffer at 4°C until
used.
In the first experiment GFR (mI/mm/kidney) based on
inuiin clearance was calculated as
urine '4C-inulin (cpm/ml) x urine volume (mI/mm)
plasma '4C-inulin (cpm/ml)
and GFR (mi/mm/kidney) based on 57Co-EDTA clearance was
calculated as
tracer activity in left kidney, ureter and urine (cpm)
pump tracer activity (cpm)
x pump withdrawal rate (mI/mm) x (1 — Hct)
In the s"' experiment in which only 57Co-EDTA clearance
was assessed, GFR (mi/mm/kidney) was calculated as:
tracer activity in both kidneys, ureters, bladder and urine (cpm)
pump tracer activity (cpm) x 2
x pump withdrawal rate (mi/mm) x (1 — Hct)
The mathematical basis for this latter approach for assessing
GFR is the following:
A
GFR= (1)
j_0Tc(t) dt
where A is the total tracer radioactivity (cpm) in glomerular
filtrate produced from time 0 (57Co-EDTA injection) to T (when
the animal is killed and blood pressure drops to zero), and c(t)
is the radioactivity per unit of plasma (cpmlml) at time (t). Since
plasma 57Co-EDTA activity, c(t), changes rapidly in the initial
portion of the experiment, the denominator is obtained by
continuous withdrawal of arterial blood (0.055 mllmin). Using
the pump withdrawal rate, v, the denominator in equation 1 can
be converted as follows. In the time period dt, the volume of
plasma (ml) withdrawn by the pump is
v.(1—Hct).dt (2)
where Hct is the arterial hematocrit and is assumed to remain
constant. The pump withdraws arterial blood constantly up to
time T, and total 57Co-EDTA radioactivity in the pump, Q
(cpm), can be calculated as
fTQ = J c(t) v (1 — Hct) dt (3)
Jo
Since v and (1 Hct) are constant, these terms can be placed
outside the integral as
fTQ = v (1 — Hct). c(t) dt (4)
Jo
...jTc(t) dt = v• (1— Hct) (5)
From equations 1 and 5, GFR is calculated as
A
GFR = v. (1 — Hct) (6)
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The validity of equation 6 is contingent on several conditions
and assumptions being met. First, the arterial hematocrit must
remain constant during blood withdrawal. Second, the with-
drawal pump collects arterial blood only from time 0 to T and is
stopped at the same time blood pressure drops to zero in the
kidney. Third, the term A represents total 57Co-EDTA radio-
activity (cpm) filtered by glomeruli (including filtered 57Co-
EDTA still in renal tubules as well as that in ureters and
bladder). Since 57Co-EDTA activity in the whole kidney in-
cludes radioactivity in intravascular and peritubular spaces in
addition to 57Co-EDTA filtered by glomeruli, corrections must
be made for 57Co-EDTA activity in these compartments unless
it can be shown to be negligible relative to that filtered by
glomeruli. Finally, the validity of this method is contingent on
the reliability of a relatively brief (—5 mm) assessment of GFR
being representative of GFR measurements obtained over the
one to two hour time frame used for conventional inulin
clearance.
Statistics
Comparability of GFR data generated by 57Co-EDTA versus
inulin clearance was assessed by analysis of variance, the
paired t-test, Student's f-test, and a linear regression model
using the SAS PROC REG program [14]. Homogeneity of
variance of GFR data over the entire range of GFR values
observed was assessed by a test for heteroskedasticity [15].
Data are reported as means SD.
Results
Arterial plasma 57Co-EDTA activity curves were identical in
control and diabetic rats (Fig. 1) with the peak occurring —30
seconds after injection followed by a time-dependent decrease
in activity described by the equation: % activity = 78.91t°5° (t
= 1 to 10 mm). Blood pressure and hematocrit did not differ
Table 1. Gravimetric, metabolic, and hemodynamic data in control
and in Group I diabetic rats (duration of diabetes = 2 weeks)
Control DiabeticN=6 N=8
Body weight g 319 51 292 28
Kidney weight g 1.22 0.13 1.54 0.21"
GFR mI/mm/kidney
'4C-jnulirj 1.36 0.16 1.89 0.26a
57Co-EDTA 1.40 0.17 1.92 0.24a
Urine flow rate jd/min/kidney 3.11 0.91 9.12 4.20"
Blood pressure torr 102 12 103 13
Hematocrit% 45 3 45 3
between the two inulin clearance periods and the 57Co-EDTA
clearance period for each rat (data not shown), or between the
control and diabetic groups (Table 1). A total of 14 clearances
were obtained from control and diabetic rats by each method in
the first experiment (Fig. 2). GFR was increased -'1.4-fold in
diabetic rats versus controls by both clearance methods (Table
1, Fig. 2). The correlation coefficient (r) for GFR values
obtained by the two methods was 0.993 (P < 0.001) and their
relationship to each other was described by the equation y =
l.016x — 0.058. The slope of the regression line was not
significantly different from y = x (P > 0.66) with 95% confi-
dence limits of 0.948 to 1.084. Similarly, the intercept did not
differ significantly from 0 (P > 0.35) with 95% confidence limits
of —0.176 to +0.060. A more powerful multivariate test (looking
at slope and intercept together) indicated, however, that the
regression of inulin clearance versus 57Co-EDTA clearance
differed from identity (that is, slope = 1 and intercept 0) at P
= 0.043. The test for heteroskedasticity indicated that there was
no significant difference in the variance of GFR data over the
entire range of GFR values observed (P > 0.76).
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Fig. 1. Plasma 57Co-EDTA activity in 2 control (0) and 2 untreated
diabetic rats (A) following intravenous injection of 57Co-EDTA. The
duration of diabetes was 2 weeks.
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Values are mean I SD.
a P < 0.001 and b P < 0.01 vs. controls by Student's t-test
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Fig. 2. 57Co-EDTA versus '4C-inulin clearance in 6 control (0) and S
Group I untreated diabetic (A) rats (duration of diabetes = 2 weeks). y
= 1.016x — 0.058, r = 0.993 (P < 0.001).
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Control Diabetes Diabetes
+
insulin
Bodywt 384 25 315 26* 361 22
Kidneywt 1.4 0.2 2.0 0.4t 1.6 0.1
Fig. 3. GFR (mean SD) based on renal clearance of plasma 57Co-
EDTA in control rats, Group 2 insulin-treated diabetic rats, and Group
3 untreated diabetic rats (duration of diabetes = 4 weeks). Body weight
and kidney weight (mean SD) are in g. Significantly different from
controls at *p < 0.01 and fP < 0.05.
GFR values (for controls and diabetics together) obtained by
inulin clearance and by 57Co-EDTA clearance (shown in Fig. 2)
were 1.661 0.345 (SD) and 1.693 0.337 mI/mm/kidney,
respectively. The difference in GFR values obtained by these
two methods was 0.032 0.041 mi/mm/kidney (P = 0.012 by
the paired (-test) and was independent of absolute GFR values
obtained by either method (r = 0.25, P = 0.40 for GFR vs.
inulin clearance and r = 0.12, P = 0.66 for z GFR vs.
57Co-EDTA clearance). Consistent with the latter finding, the
GFR for control rats (0.037 0.045) did not differ from that for
diabetics (0.029 0.041, P > 0.5).
In the second experiment, using only 57Co-EDTA clearance,
GFR was significantly elevated (Fig. 3) in insulin-treated dia-
betics versus controls (P < 0.05). The activity of '251-BSA in
the kidneys, ureters, and bladder corresponded to an equivalent
plasma volume of 0.061 0.0 14 mug tissue wet wt. The activity
of 57Co-EDTA in this volume of plasma (5 mm after injection)
accounted for only 0.35 0.15% of total 57Co-EDTA activity in
kidneys, ureters, bladder, and urine.
Discussion
The close agreement (Table 1, Fig. 2) and the highly signifi-
cant correlation between GFR clearances based on constant
infusion of 14C-inulin versus a single bolus injection of 57Co-
EDTA in the same rat indicates that a five minute 57Co-EDTA
clearance period provides a representative and reproducible
measurement of GFR and that glomerular filtration of 57Co-
EDTA is virtually identical to that for '4C-inulin over the range
of normal and elevated GFR values observed in these experi-
ments. The latter conclusion is supported by previous observa-
tions that radiolabeled inulin mixed with 57Co-EDTA and
injected (as a bolus) into control and diabetic rats gave GFR
values identical to those for 57Co-EDTA after a two minute
tracer circulation time [161.
The likelihood that this close correspondence between GFR
values obtained by inulin clearance and 57Co-EDTA clearance
in normal rats and in rats with elevated GFR values would also
hold in rats with subnormal GFR values is supported by the
findings that: 1) GFR for the two methods was independent of
absolute GFR values obtained by both methods, 2) 95% confi-
dence limits for the regression of inulin clearance on
EDTA clearance encompassed equal clearance values for both
methods, and 3) the test for heteroskedasticity indicated that
the variance in GFR data obtained by the two methods did not
differ over the entire range of GFR values observed. The finding
that the very small differences in GFR values and in the
regression of inulin clearance on 57Co-EDTA clearance
achieved statistical significance attests to the reproducibility of
both methods for assessing GFR.
Although the difference in GFR values obtained by these two
methods is trivial, the fact that it is so reproducible and is
statistically significant indicates that it is real. This difference
could be explained, in part, by the presence of 57Co-EDTA in
interstitial spaces [171 as well as in the vasculature and/or by
subtle differences in renal handling of the two tracers which
would be difficult to document because of the small magnitude
of the difference. Among the latter possibilities are: 1) the much
smaller molecular weight of 57Co-EDTA (mol wt = 349) than
that of inulin (mol wt —5000); thus 57Co-EDTA might permeate
glomerular capillaries slightly more readily than inulin, and 2) a
subtle difference in binding of the tracers to tubular epithelium
or in tubular reabsorption of the tracers.
These observations suggest that GFR remains relatively
constant even though urine flow can fluctuate markedly over
short time intervals. It is this fluctuation in urine flow rate that
necessitates long urine collections in well hydrated (fluid sup-
plemented) subjects for accurate measurement of GFR based
on recovery of tracer in the urine with constant tracer-infusion
methods [18]. The close agreement between GFR values based
on '4C-inulin versus 57Co-EDTA clearance also indicates that
the 57Co-EDTA content of the kidney not filtered by glomeruli
(that is, in the vasculature and in peritubular spaces, such as
interstitium) is indeed negligible under these experimental con-
ditions. This conclusion is consistent with the finding that
intravascular 57Co-EDTA accounted for only 0.35% of total
57Co-EDTA activity in the kidneys, ureters, bladder, and urine.
The good correspondence between GFR values obtained by
both clearance methods also indicates that the volume of blood
removed by the constant withdrawal pump does not signifi-
cantly influence GFR under these conditions. The comparable
(albeit not identical) GFR values in control and in diabetic rats
in two independent experiments (Table 1, Fig. 3) attest to the
reproducibility of GFR estimates based on a five minute clear-
ance of 57Co-EDTA. These increases in GFR in diabetic rats are
consistent with previously published data using a two minute
circulation time [16, 171. The small difference in GFR values in
diabetic rats in the two experiments may be related to the
differences in duration and severity of diabetes in the two
studies.
The selection of a five-minute clearance period for determi-
nation of GFR by 57Co-EDTA clearance is based principally on
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two considerations. The first is that at shorter circulation times,
when plasma 57Co-EDTA activity is rapidly declining (Fig. 1),
any discrepancy between the time the withdrawal pump is
stopped and the aorta is severed will result in progressively
larger errors in estimates of GFR. Such errors will be reduced
still further with tracer circulation times longer than five min-
utes; however, this will require removal of larger volumes of
blood by the withdrawal pump which may impact on GFR. A
five second discordance in the time between severing the aorta
and stopping the withdrawal pump after a two minute tracer
circulation time will result in a —4% difference in the area under
the curve (Fig. 1) which corresponds to a 4% error in the
estimate of GFR. In contrast, only a 1% error results from the
same five second discordance if the tracer is allowed to circu-
late for five minutes. In practice it is not difficult to keep the
discordance well under five seconds. In light of these consider-
ations, approximately five minutes is a reasonable tracer circu-
lation time for assessment of GFR under these experimental
conditions.
There are a number of advantages to assessment of GFR by
a five minute clearance of 7Co-EDTA (or of any other suitable
tracer) by this method. Surgical and anesthetic stress are
minimized since the method is noninvasive (to the urinary
tract), requiring only cannulation of peripheral arteries and
veins for injection of isotopes and blood withdrawal. Since the
duration of the whole procedure is so brief and, since blood and
fluid loss associated with vascular cannulations are minimal,
there is no need for continuous intravenous fluid or plasma
repletion. In addition, estimates of GFR obtained by this
method are unaffected by fluctuations in urine flow rate which
markedly influence estimates of GFR based on recovery of
tracer in the urine (as in the conventional inulin clearance
method). These advantages may permit assessment of GFR in
animals unable to tolerate surgical stress, prolonged anesthesia,
blood loss, etc., associated with more invasive procedures for
estimating GFR. Lastly, the use of a clearance tracer labelled
with a gamma-emitting isotope permits quantification of the
tracer in tissues and blood by gamma spectrometry which
requires much less time and effort than quantification of tracers
labelled with beta-emitting isotopes by liquid scintillation spec-
trometry. The major limitation of this method is that it requires
sacrifice of the animal. This is not a problem in many experi-
ments in which repetitive measures of GFR are not required. As
is true for all methods in which GFR is assessed in anesthetized
animals, the GFR values obtained may be lower than in awake
animals [19].
Since this method utilizes a constant withdrawal pump, renal
blood flow can also be readily assessed by injection of radiola-
beled microspheres into the left ventricle via a carotid artery
cannula. We routinely employ 85Sr-labeled microspheres (15 )
with 57Co-EDTA for measurement of renal blood flow and GFR
in the same animal [16, 17].
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